Author Archive for: panglobal

Celonic Group, a biologics contract development and manufacturing organisation based in Basel, Switzerland, has entered into a strategic alliance with CARBOGEN AMCIS to establish an end-to-end platform for antibody-drug conjugate (ADC) production. The collaboration combines Celonic’s upstream biologics capabilities with CARBOGEN AMCIS’s downstream expertise in payload synthesis, conjugation chemistry, and sterile fill-finish operations.

Polpharma Group, a major pharmaceutical manufacturer serving Central and Eastern Europe and Central Asia, has confirmed a planned leadership transition effective 1 January 2026. Markus Sieger will step down as chief executive officer after ten years of service, with Sebastian Szymanek succeeding him in the role.